Quantcast

Latest BSD Stories

2008-10-27 09:00:12

SALT LAKE CITY, Oct. 27, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today reported that the company well exceeded its goal and was among the top participants in its local area in the American Cancer Society "Making Strides Against Breast Cancer" walkathon as part of the National Breast Cancer Awareness Month (NBCAM). October is designated as National Breast Cancer Awareness Month in the United States. Working in partnership with other local businesses and individuals, the...

2008-10-14 09:00:45

SALT LAKE CITY, Oct. 14, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) announced today that a member of its Board of Directors, Dr. Michael Nobel, was the keynote speaker at the Japanese Cancer Symposium recently concluded at the Shizuoka Cancer Center in Shizuoka, Japan. The symposium addressed the theme, "Fulfilling the Promise of Personalized Medicine in Cancer Therapy: Development of the Medical Engineering Platform." The symposium was sponsored by the Frontier...

2008-10-08 09:00:51

SALT LAKE CITY, Oct. 8, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) announced today that the company will present its BSD-2000 hyperthermia therapy system as well as its MicroThermX-100 ablation system (which is being prepared for SFDA submission in China) at the 2008 China Medical Equipment Fair (CMEF) from October 29 through November 1, 2008 in Suzhou, China. The company's objective at CMEF is to leverage the growing clinical interest in the use of BSD Medical's systems...

2008-10-06 09:00:57

SALT LAKE CITY, Oct. 6, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today announced that the European Society for Therapeutic Radiation and Oncology (ESTRO) recently held in Goteborg, Sweden included a symposia with lectures and discussions by key thought leaders on the use of hyperthermia therapy for the treatment of cancer. A summary of the presentations at the symposia is as follows: Olav Dahl MD, Bergen, Norway and Stefan Bodis MD, Aarau, Switzerland: Targeted Hyperthermia...

2008-10-01 09:00:49

SALT LAKE CITY, Oct. 1, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on the company's attendance and exhibitions at both the ASTRO (American Society for Therapeutic Radiology and Oncology) and the SROA (The Society for Radiation Oncology Administrators) annual conferences held at the Boston Convention and Exhibition Center in Boston, Massachusetts and the Hyatt Hotel in Cambridge, Massachusetts. The company also announced attendance at the RRS (Radiation Research...

2008-09-30 09:01:00

SALT LAKE CITY, Sept. 30, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today announced the purchase of two new BSD-500 hyperthermia cancer therapy systems in Poland from the Holy Cross Hospital (Swietokrzkzyskie Cancer Center) in Kielce, Poland and the Center of Oncology Maria Sklodowska-Curie Memorial Institute in Krakow, Poland. These two cancer centers join six other centers that have purchased hyperthermia systems from BSD Medical in Poland, and the many BSD hyperthermia...

2008-09-23 09:01:09

SALT LAKE CITY, Sept. 23, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) announced today that the addition of hyperthermia to chemotherapy was recommended as standard therapy for soft tissue sarcoma by the European Society for Medical Oncology (ESMO), the leading European professional medical oncology organization comprising a network of more than 5,000 oncology professionals in over 100 countries. The use of hyperthermia as standard treatment for soft tissue sarcomas was debated...

2008-09-18 09:00:49

SALT LAKE CITY, Sept. 18, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) announced today that it will attend and have an exhibit at the 50th ASTRO (American Society for Therapeutic Radiology and Oncology) annual conference to be held at the Boston Convention and Exhibition Center in Boston, Massachusetts on September 21 - September 25, 2008. ASTRO's annual conference is the largest radiation oncology conference held in America and the premier worldwide scientific meeting in...

2008-09-15 09:00:57

SALT LAKE CITY, Sept. 15, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today reported that a new article in Current Option in Oncology (see 2008, 20:pages 438-443) highlights strong success from the use of the BSD-2000 manufactured by BSD Medical Corporation, in treating patients with high risk soft tissue sarcomas. Central to the article's review of sarcoma studies using the BSD-2000 is the results of a phase III study involving 341 randomized patients with high risk soft...

2008-08-20 09:01:30

SALT LAKE CITY, Aug. 20, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that a report of two case studies has been published in the current issue of the International Journal of Hyperthermia (see vol. 4, pp. 327-335) that demonstrate the ability of the BSD-2000/3D/MR to produce high quality thermal imaging of cancer treatments in progress, even when interfering frequencies are introduced. The results of these studies are significant in showing the versatility...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.